BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29916535)

  • 1. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
    Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
    Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
    Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
    Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2-GPI: a novel factor in the development of hepatocellular carcinoma.
    Jing X; Piao YF; Liu Y; Gao PJ
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1671-80. PubMed ID: 20204408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor κB in Liver Cancer Cells.
    Jing X; Tian ZB; Gao PJ; Han NJ; Xu YH; Zhang H; Ding XL; Wang XW; Man X; Zhang CP
    Clin Lab; 2015; 61(9):1239-45. PubMed ID: 26554243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex.
    Wang T; Ouyang H; Zhou H; Xia L; Wang X; Wang T
    Int J Mol Med; 2018 Oct; 42(4):1955-1966. PubMed ID: 30085340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-β
    Zha C; Zhang W; Gao F; Xu J; Jia R; Cai J; Liu Y
    Neuropharmacology; 2018 Aug; 138():140-150. PubMed ID: 29883691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OxLDL/β2GPI/anti‑β2GPI Ab complex induces inflammatory activation via the TLR4/NF‑κB pathway in HUVECs.
    Zhang G; Cai Q; Zhou H; He C; Chen Y; Zhang P; Wang T; Xu L; Yan J
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro.
    Zhang R; Real CI; Liu C; Baba HA; Gerken G; Lu M; Broering R
    Int J Cancer; 2017 Jul; 141(2):354-363. PubMed ID: 28419472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells.
    Liu Y; Gao P
    Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
    Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
    [No Abstract]   [Full Text] [Related]  

  • 17. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway
    Front Immunol; ; . PubMed ID: 33717111
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.